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Kaohsiung, Taiwan.Adenosine (Ado), an endogenous nucleoside, can stimulate corticosterone synthesis in adrenal cells
via the A2A/A2B adenosine receptors (ARs). This study evaluated the contribution of protein kinase C
(PKC) isoforms in Ado-induced steroidogenesis. The PKC inhibitor calphostin c blocked Ado-induced
steroidogenesis, the mitogen-activated protein kinase (MEK)-extracellular signal-related regulated
kinase (ERK)-cyclic AMP responsive element-binding protein cascade, and the mRNA expression
of steroidogenic acute regulatory protein and CYP11B1. Further analyses revealed that PKCl was
indeed activated by Ado. Moreover, downregulation of PKCl by small interfering RNA (siRNA) inhib-
ited Ado-stimulated steroidogenesis and ERK phosphorylation. Finally, inhibition of either A2AAR or
A2BAR led to the suppression of PKCl phosphorylation. Together, these ﬁndings suggest that A2AR-
PKCl-MEK signaling mediates Ado-stimulated adrenal steroidogenesis.
Crown Copyright  2010 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. All rights reserved.1. Introduction actions of Ado in cells are operated via adenosine receptorsTraditionally, corticosterone production in adrenal cells is con-
trolled by protein kinase A (PKA) and protein kinase C (PKC) sys-
tems [1,2]. In addition, extracellular signal-related regulated
kinase (ERK) and tyrosine kinase, including Janus kinase 2 (JAK2)
and Src kinase, also regulate steroidogenesis in adrenal Y-1 cells
and bovine adrenal glomerular cells [3,4]. The downstream targets
of the activation of these speciﬁc kinases include hormone sensi-
tive lipase, steroidogenic factor 1, cyclic AMP responsive-element
binding protein (CREB), steroidogenic acute regulatory protein
(StAR) proteins, and 11b-hydroxylase [5–8].
Adenosine (Ado) is a naturally occurring purine nucleoside
derived from the breakdown of adenosine triphosphate. Thed by Elsevier B.V. on behalf of Fede
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hsiung Medical University,(ARs), which are classiﬁed into four subtypes, A1, A2A, A2B, and
A3 [9]. ARs are G protein-coupled receptors (GPCRs), with A1AR
and A3AR interacting with Gi/o proteins to inhibit adenylyl cy-
clase, and A2AAR and A2BAR interacting with Gs, Gi/o or Golf [9]
to induce the activation of various signaling mechanisms in dif-
ferent cell types.
One of the physiological functions of Ado is the stimulation of
corticosterone production in adrenal cells, which is mediated by
the activation of the A2AR-JAK2 signaling pathway [10]. However,
the JAK2 pathway is only responsible for about half of the Ado-
stimulated adrenal steroidogenesis [10]. The nature of other sig-
naling pathways leading to Ado-induced steroidogenesis remains
to be explored. Since PKC is known to regulate adrenal steroido-
genesis, we hypothesized that PKC might participate in the Ado-
induced steroidogenesis. We tested this hypothesis in primary
cultures of adrenal cells, and tried to identify the PKC isoforms
involved in this event.2. Materials and methods
2.1. Drugs
Ado and the PKCd inhibitor rotterlin were purchased from the
Sigma Chemical Co. (St. Louis, MO). The non-speciﬁc PKC inhibitorration of European Biochemical society. All rights reserved.
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PKCab inhibitor Gö6976 were purchased from Calbiochem
(La Jolla, CA). The PKCb inhibitor LY333531 was from Enzo Life
Sciences International Inc. (Plymouth Meeting, PA). The A2AAR
antagonist ZM241385 and the A2BAR antagonist MRS1706 were
from Tocris Cookson Inc. (Avonmouth, UK).
2.2. Cell culture
Adrenal cell cultures were obtained as described by Chen et al.
(2005) [11]. Day 2–3 cultures were used in all experiments.
2.3. Corticosterone radioimmunoassay
The collected culture medium samples were assayed for corti-
costerone according to the procedure described by Chen et al.
(2005) [12].
2.4. siRNA transfection
SiCONTROL cyclophilin B (Dharmacon Corporation, Lafayette,
CO) was used to estimate the efﬁciency of siRNA silencing. SiRNAs
targeting rat PKCl coding sequences were custom-designed by
Dharmacon Corp. (Lafayette, CO). Day 2 cultures were used for
transfection, which was performed by incubation with Dharma-
FECT transfection reagent and cyclophilin B siRNA (100 nM) or
PKCl siRNA (100 nM) in culture medium for 48 h. The efﬁciency
of silencing by cyclophilin B siRNA or PKCl siRNA was veriﬁed
by RT-PCR and downregulation of PKCl protein by PKCl siRNA
was veriﬁed by Western blotting.
2.5. Western blot analysis
After various treatments, total cell homogenates were analyzed
by 10% sodium dodecyl sulfate–polyacrylamide gel electrophore-
sis. The proteins were transferred to nitrocellulose paper and Wes-
tern blotting was performed as described previously [11]. Primary
antibodies included mouse antibodies against phosphorylated
ERK1/2 (Santa Cruz Biotechnology, Santa Cruz, CA) or b-actin
(Sigma), and rabbit antibodies against phosphorylated forms of
mitogen-activated protein kinase kinase (MEK)1/2ser217/221, CREB-
ser133, PKClser916 or PKClser744/748 (Cell Signaling Technology Inc.,
Beverly, MA) diluted in Tris-buffered saline (150 mM NaCl,Fig. 1. Ado-induced steroidogenesis is time- and concentration-dependent and inhibited
steroidogenesis. Adrenal cells were treated with 0.1% DMSO (vehicle) or 10, 30, or 50 l
Adrenal cells were pretreated for 30 min with the PKC inhibitor calphostin C (500 nM), th
then the culture supernatants were assayed for corticosterone. (B) Effect of calphostin C
compared to the control group. ##P < 0.01 compared to the Ado group.50 mM Tris base, 0.1% Tween, pH 8.2). The densities of the bands
on the nitrocellulose membrane were quantiﬁed by densitometry
using Gel Pro 3.1 (Media Cybernetics, Silver Spring, MD). The band
intensity of the control group was deﬁned as 100% and the densi-
ties of the band in the test samples expressed as a percentage of
this value.
2.6. Real-time quantitative polymerase chain reaction
Total cellular RNA was prepared using TRIzol reagent (Invitro-
gen, Paisley, UK) and 1 lg was reverse transcribed using the Super-
Script ﬁrst-strand synthesis system (Invitrogen, Paisley, UK) and
the cDNA generated subjected to real-time quantitative polymer-
ase chain reaction ampliﬁcation using primers speciﬁc for rat StAR
or CYP11B1 and b-actin as a housekeeper control. The primers for
rat StAR, CYP11B1 and b-actin were designed using primer3 soft-
ware and were: StAR forward, TTCGCTATCACCATCAGCACCG; StAR
backward, CCTGGCACCTCACTCTCTTC; b-actin forward, GCCATTGT-
TACCAACTGGGACG; b-actin backward, TTGATGTCACGCACGAT-
TTCC; CYP11B1 forward, CCCAAGACACTGAAGCCCTTTG; CYP11B1
backward, GCCCCATTTAGCAAGAACACAC. The SYBR green Advan-
tage qPCR premix kit was purchased from Clonetech Laboratory,
Inc. (Mountain View, CA) and the reaction time was according to
the manufacturer’s instructions.
2.7. Statistical analysis
All experiments were performed at least three times and the
values are expressed as the mean ± S.D. Statistical differences were
determined using the Kruskal–Wallis test and corrected using the
Mann–Whitney test. P < 0.05 was considered a statistically signiﬁ-
cant difference.
3. Results
3.1. Ado-stimulated steroidogenesis is mediated by PKC
As shown in Fig. 1A, application of Ado led to a concentration-
dependent increase in corticosterone production in adrenal cells.
These effects were observed at as early as 3 h post treatments,
and were much more prominent at 6 h post treatments. In all sub-
sequent experiments, 30 lM Ado was used. In addition to PKA,
ERK, or JAK2, it has been demonstrated that PKC also plays anby calphostin C. (A) Time- and concentration-dependent effects of Ado on adrenal
M Ado for 3 or 6 h, then the culture supernatants were assayed for corticosterone.
en with 0.1% DMSO or 30 lM Ado for 6 h in the continued presence of the inhibitor,
. The results shown are the mean ± S.D. for three separate experiments. **P < 0.01
4444 Y.-C. Chen et al. / FEBS Letters 584 (2010) 4442–4448important role in steroidogenesis in adrenal cells [13,14]. We
therefore examined the role of PKC in Ado-mediated steroidogen-
esis using a non-speciﬁc PKC inhibitor, calphostin C. As illustrated
in Fig. 1B, 500 nM calphostin C signiﬁcantly reduced Ado-stimu-
lated corticosterone production by about 67%.
3.2. The PKC-MEK-ERK cascade regulates Ado-induced steroidogenesis
Since recent studies have shown that PKC may participate in the
effects of A2AR and A2BR stimulation by ERK activation [15–18], we
examined the effects of Ado on MEK and ERK and found that both
kinases were activated (Fig. 2A). Since PKC was required for Ado-
stimulated steroidogenesis, we examined whether it was the
upstream effector of the MEK-ERK pathway. Pretreatment withFig. 2. Ado induces phosphorylation of MEK/ERK and CREB via PKC. Adrenal cells were t
Cell lysates were then immunoblotted for phosphorylated MEK1/2 or ERK1/2 (A) or CREB
analysis (mean ± S.D.) n = 5. The data are expressed as a percentage of the 0-min value.
Fig. 3. Expression of StAR mRNA and CYP11B1 mRNA induced by Ado is PKC-dependen
then with 30 lM Ado for 6 h, then relative mRNA expression of StAR/b-actin (A) or CYP
n = 4 in A, n = 5 in B. The data are expressed as a percentage of the DMSO value and are tcalphostin C (500 nM) inhibited the Ado-induced phosphorylation
of MEK1/2 and ERK1/2 (Fig. 2A). These data suggest that Ado-
stimulated steroidogenesis is mediated by activation of the PKC-
MEK-ERK signaling cascade.
3.3. Ado induces CREB phosphorylation and StAR mRNA expression and
both are mediated by PKC
PKC activation is required for CREB phosphorylation and StAR
expression in Leydig cells [19]. CREB, one of the important tran-
scription factors in steroidogenesis, controls StAR gene transcrip-
tion [20–22]. The rate-limiting step in steroidogenesis is
mediated by StAR protein [3]. We therefore examined whether
PKC activation led to CREB phosphorylation and StAR mRNAreated with 30 lM Ado for 5 min after 30 min of 500 nM calphostin C pretreatment.
(B). GADPH was used as the internal control. The bar graph shows the densitometric
*P < 0.05 vs. the DMSO control. #P < 0.05 and ##P < 0.01 vs. the Ado group.
t. Adrenal cells were incubated with 0.1% DMSO or 500 nM calphostin c for 30 min,
B11/b-actin (B) was analyzed by real-time quantitative polymerase chain reaction.
he mean ± S.D. **P < 0.01 vs. the DMSO control. #P < 0.05 vs. the Ado-treated group.
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CREB at Ser133 and (Fig. 2B). Real-time quantitative polymerase
chain reaction analysis demonstrated that StAR mRNA levels were
increased about fourfold after 6 h treatment with Ado (Fig. 3A).
Furthermore, both effects were attenuated by pretreatment of
the cells with 500 nM calphostin C.
Corticosterone production requires the translation of
cytochrome P450 hydrolase (CYP11A1, CYP17, CYP21, CYP11B1),
hormone sensitive lipase, and StAR [23]. Among them, 11b-
hydroxylase, encoded by CYP11B1 gene, catalyzes the production
of corticosterone [24]. Ado induced mRNA expression of CYP11B1,Fig. 4. PKC isoform expression and time course dependence of Ado-induced PKCl phos
PKCa, bI, bII, e, d, f, or l. (B) Immunoblots of PKCl serine phosphorylation induced by Ado
were analyzed for phosphorylated PKCl (Ser916) or phosphorylated PKCl (Ser744/748).
expressed as a percentage of the control value and are the mean ± S.D. n = 5. *P < 0.05 a
Fig. 5. Effects of PKCl siRNA on Ado-stimulated steroidogenesis. (A) siRNA-mediated
marker. Lane 2: negative control siRNA. Lane 3: siRNA-PKCl (100 nM). b-Actin mRNA w
siRNA group. Lane 5: immunoblot of PKCl in the siRNA-PKCl group n = 3. (B) Effect of siR
to three groups: negative control siRNA incubated with 0.1% DMSO, negative control siR
The results are the mean ± S.D. for three experiments. *P < 0.01 vs. the DMSO group. ##Pand this effect was abolished by PKC inhibition (calphostin C
pretreatment) (Fig. 3B). These results demonstrate that CREB
phosphorylation, StAR mRNA expression, and CYP11B1 mRNA
expression are downstream events of the Ado-induced PKC
activation.
3.4. Involvement of A2AR-PKCl in Ado-stimulated steroidogenesis
Rat adrenocortical cells expressed the PKCa, bI, bII, e, d, f, and l
isoforms (Fig. 4A). Since the PKCab inhibitor Gö6976 (2–10 lM),
the PKCb inhibitor LY333531 (0.01–1 lM), the PKCe inhibitorphorylation. (A) PKC isoforms in adrenal cells. Total cell lysates were analyzed for
. Adrenal cells were treated with 30 lM Ado for the indicated time, then cell lysates
b-Actin was used as the internal control. (C and D) Densitometric data. The data are
nd **P < 0.01 vs. the 0 min value.
knock down of PKCl mRNA (top panel) and protein (bottom panel). Lane 1: DNA
as used as the internal control. Lane 4: immunoblot of PKCl in the negative control
NA-PKCl on Ado-induced steroidogenesis. Cultured rat adrenal cells were assigned
NA incubated with 30 lM Ado, PKCl-siRNA incubated for 15 min with 30 lM Ado.
< 0.01 vs. the Ado group.
Fig. 6. SiRNA-PKCl prevents Ado-induced phosphorylation of ERK. The cells were transfected with siRNA-PKCl or siNeg for 48 h, then were incubated with DMSO or 30 lM
Ado for 15 min and cell lysates were analyzed for pERK by immunoblotting, with GADPH as the internal control. (A) Typical result. (B) Densitometric data. The data are
expressed as a percentage of the control value and are the mean ± S.D. for three experiments. *P < 0.05 vs. the DMSO group. #P < 0.01 vs. the Ado group.
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not block Ado-induced steroidogenesis (data not shown), we
hypothesized that PKCl was the most likely candidate for mediat-
ing the effect of Ado. Activation of PKCl is dependent on phosphor-
ylation of Ser916 or Ser744/748 [25]. Using speciﬁc antibodiesFig. 7. PKCl phosphorylation is mediated through the A2AR, JAK2 kinase, and PKC. Adre
5 lM ZM241385 (C) or 20 nM MRS1706 (D), then incubated with 30 M Ado for 5 min, an
(Ser744/748) (D). n = 3 in A and B. GADPH or b-actin was used as the internal control. The
are expressed as a percentage of the control value. **P < 0.01 vs. the DMSO group. *P < 0against PKCl phosphorylated at Ser916 or Ser744/748, we demon-
strated that protein levels of both pPKCl (Ser916) and pPKCl
(Ser744/748) were signiﬁcantly increased by Ado treatment
(Fig. 4B–D). To further verify that PKCl was relevant to Ado-stim-
ulated steroidogenesis, we knocked down its expression by usingnal cells were pretreated for 30 min with 500 nM calphostin C (A), 50 M AG490 (B),
d immunoblotted for phosphorylated PKCl (Ser916) (A–C) or phosphorylated PKCl
bar graph represents the densitometric data (mean ± S.D.) n = 5 in C and D. The data
.05 vs. the DMSO control. ##P < 0.01 vs. the Ado group, #P < 0.05 vs. the Ado group.
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mRNA levels by about 70% and PKCl protein levels by about 85%,
(Fig. 5A). PKCl siRNA transfection also signiﬁcantly inhibited
Ado-stimulated corticosterone production (Fig. 5B) and the phos-
phorylation of ERK (Fig. 6A and B).
Calphostin C is an inhibitor of PKCa, b, c, e, d, n as well as PKCl
[26]. As expected, calphostin C pretreatment abolished the Ado-in-
duced PKCl activation (Fig. 7A). Interestingly, AG490, a JAK2 inhib-
itor, also inhibited the Ado-induced PKCl activation, suggesting
that JAK2 is also the upstream effector of PKCl (Fig. 7B). Finally,
we examined whether A2AR activation indeed leads to PKCl acti-
vation was the downstream molecule for the A2AR. Both the
A2AAR antagonist ZM241385 (5 lM) and the A2BAR antagonist
MRS1706 (20 nM) signiﬁcantly reduced Ado-induced phosphoryla-
tion of PKCl Ser916 (Fig. 7C) and Ser744/748 (Fig. 7D), conﬁrming
that A2BAR and A2A AR are involved in Ado-induced PKCl
activation.4. Discussion
Our previous studies have demonstrated that one of the
signaling pathways for Ado-induced steroidogenes is the A2AAR/
A2BAR-JAK2-MEK-ERK-CREB cascade [10]. This study further dem-
onstrated that (1) pretreatment with PKC inhibitor calphostin C
inhibited Ado-stimulated steroidogenesis by about 67%, (2) Ado in-
duced activation of PKCl, and (3) PKCl knockdown by siRNA de-
creased Ado-stimulated steroidogenesis by about 50%. These
results indicate that PKCl is the major isoform contributing to
Ado-stimulated steroidogenesis. In addition, Ado increased mRNA
expression of StAR and CYP11B1, and CREB protein expression.
PKCl is involved in aldosterone and cortisol production induced
by angiotensin II in adrenal tumor cell line [27,28]. In the present
study, we characterized the role of PKCl in Ado-mediated steroi-
dogenesis in primary cultures of rat adrenal cells. PKCl can be acti-
vated by the phosphorylation mediated by other PKC isoforms [29]
or by a PKC-independent mechanism [30,31]. However, the PKC-
dependent PKCl activation appears unlikely to occur in the current
cell model, since several selective PKC isoform inhibitors did not
block Ado-induced steroidogenesis and PKCl phosphorylation
(data not shown). It has been shown that GPCR-dependent phos-
phorylation of the activation loop Ser744 and Ser748 is the mech-
anism involved in late phase of PKCl activation occurring in cells
stimulated by bomebsin, a GPCR agonist [32]. Since AR is a member
of GPCR, Ado-induced PKCl activation could be mediated by G pro-
tein-coupled receptor activation induced by the A2AR. Besides, we
found that PKCl serine phosphorylation was also mediated by the
JAK2 kinase in rat adrenocortical cells.
We previously proposed a pathway, the Ado-A2AR-JAK2-MEK-
ERK, which contributes to Ado-stimulated steroidogenesis in rat
adrenal cells [10]. Here, we further demonstrate that PKCl is an
intermediate molecule between the A2AR and MEK-ERK-CREB. This
is a novel pathway for corticosterone synthesis. Since Ado is an
endogenous nucleoside present in all type of cells in the body, its
effect might be universal. It is very likely that other types of steroi-
dogenic cells are also affected by Ado, which deserves further
investigation. Thus, we propose that Ado-induced steroidogenesis
in adrenal cells is regulated by at least two distinct pathways,
the Ado-A2AR-JAK2-MEK-ERK cascade and the Ado-A2AR-PKCl-
MEK-ERK cascade.
Most studies only focused on the roles of PKCa and PKCe in the
adrenal cortex [33]. This study, for the ﬁrst time, shows the pres-
ence of isoforms other than PKCa and PKCe in adrenal cells. Cal-
phostin C is an inhibitor of PKCa, b, c, e, d, n as well as PKCl
[26]. Calphostin C and PKCl siRNA signiﬁcantly inhibits Ado-in-
duced corticosterone production by about 67% and 50%, respec-tively, indicating that PKCl accounts for 75% of the calphostin C
effect on steroidogenesis. Other PKC isoforms such as PKCc and f,
which are sensitive to calphostin C inhibition, may play a minor
role in Ado-induced steroidogenesis.
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